Table 2 Baseline characteristics of follow-up subjects and non-follow-up subjects (n = 808)
At baseline | Follow-up (n = 612) | Non-follow-up (n = 196) | p value | ||
|---|---|---|---|---|---|
Mean | (95 % CI) | Mean | (95 % CI) | ||
Age (years) | 8.65 | (8.52–8.77) | 8.77 | (8.56–8.98) | 0.639 |
Height (cm) | 131.1 | (130.3–131.9) | 131.3 | (129.9–132.8) | 0.388 |
Weight (kg) | 29.9 | (29.2–30.5) | 30.7 | (29.4–32.0) | 0.021 |
POW (%) | 2.63 | (1.45–3.81) | 4.64 | (2.10–7.17) | 0.101 |
Obese (n, %) (n = 99) | 61 | (10.0 %) | 38 | (19.4 %) | <0.001* |
LDL-C (mg/dL) | 95.2 | (93.4–97.0) | 95.4 | (92.4–98.3) | 0.082 |
HDL-C (mg/dL) | 67.6 | (66.5–68.6) | 66.8 | (64.9–68.7) | 0.145 |
LDL-C/HDL-C | 1.47 | (1.43–1.51) | 1.49 | (1.43–1.56) | 0.099 |
TGa (mg/dL) | 88.5 | (85.2–92.0) | 93.0 | (86.2–100.4) | 0.252 |
Hs-CRPa (mg/dL) | 0.038 | (0.035–0.041) | 0.036 | (0.032–0.040) | 0.409 |